Alexander C Kagen, MD
img_Alexander C Kagen
SITE CHAIR, DEPARTMENT OF DIAGNOSTIC, MOLECULAR AND INTERVENTIONAL RADIOLOGY, MOUNT SINAI WEST, MOUNT SINAI MORNINGSIDE | Icahn School of Medicine at Mount Sinai
PROFESSOR | Diagnostic, Molecular and Interventional Radiology
Are you a patient?
Specialties
Radiology
Research Topics
Cancer, Cardiovascular, Computed Tomography, Imaging, Liver, MRI, Magnetic Resonance Imaging, Prostate
MRI
Dr. Kagen has worked with engineers and data scientists in artificial intelligence and machine learning to expedite diagnoses of various conditions, deploy models to improve efficiency and throughput, and to help uncover bias. He is also a recognized leader in developing novel ways to use MRI to characterize and monitor patients with lymphedema, and to evaluate pre-operatively breast cancer patients undergoing autologous-based tissue flap reconstruction. Previously, he has used novel MRI techniques and coils in the field of prostate MRI in order to improve patient comfort and image quality during prostate MRI examinations. He also focuses his research on diseases of the liver, with special attention to novel molecular imaging agents in MRI which can help provide insight into hepatocellular tumor biology.

MD, SUNY Downstate Health Sciences University - College of Medicine

Internship, Internal Medicine, Lenox Hill Hospital

Residency, Radiology, General, SUNY Downstate Medical Center

Fellowship, Magnetic Resonance Imaging (MRI), Johns Hopkins Hospital

Certifications

American Board of Radiology

2018-2023

Top Doctors New York Metro Area

2017

Super Doctors New York

2015

Top People to Watch in Radiology 2015

2014

Super Doctors New York Rising Stars

2013

Certificate of Merit Award

RSNA

2012

Award Winning Abstract

American Roentgen Ray Society

2011

Attending of the Year

Mount Sinai Beth Israel

2011

AUR-AGFA Radiology Management Program

2010

Certificate of Appreciation

Myanmar American Medical Education Society

2008

Roentgen Resident/Fellow Research Award

RSNA

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Kagen during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Ascelia Pharma

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.